SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-136709
Filing Date
2022-05-02
Accepted
2022-05-02 16:02:25
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d680483d10ka.htm   iXBRL 10-K/A 1062296
2 EX-31.3 d680483dex313.htm EX-31.3 3766
3 EX-31.4 d680483dex314.htm EX-31.4 3888
9 GRAPHIC g680483g48d24.jpg GRAPHIC 70208
  Complete submission text file 0001193125-22-136709.txt   1565834

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20211231.xsd EX-101.SCH 5598
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20211231_cal.xml EX-101.CAL 732
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20211231_def.xml EX-101.DEF 20787
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20211231_lab.xml EX-101.LAB 27884
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20211231_pre.xml EX-101.PRE 22234
11 EXTRACTED XBRL INSTANCE DOCUMENT d680483d10ka_htm.xml XML 10550
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21392 | Film No.: 22881833
SIC: 2834 Pharmaceutical Preparations